Inspire Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Inspire Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-121	Closed	–	–	784
2020 Q4	$0	Buy	+121	New	+$498	﹤0.01%	824

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Inspire Advisors's SPPI Position: Q1 2021 in Review

Inspire Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2021, closing a stake of 121 shares.

Inspire Advisors first reported a position in SPPI in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 147 funds tracked by Wall St. Rank hold SPPI as of Q1 2021.

Inspire Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
Inspire Advisors sold 121 Spectrum Pharmaceuticals Inc shares in Q1 2021.
Inspire Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q4 2020 and held it in 1 quarter.
Inspire Advisors's Spectrum Pharmaceuticals Inc position peaked at $0 in Q4 2020.
147 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2021.

Based on Inspire Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.